• DiscoveryProbe FDA-approved Drug Library: Elevating High-...

  2025-11-08

  The DiscoveryProbe™ FDA-approved Drug Library redefines high-throughput and high-content screening with 2,320 clinically validated compounds, enabling rapid drug repositioning and novel pharmacological target identification. This comprehensive compound collection streamlines experimental workflows across oncology, virology, and neurodegeneration, delivering unparalleled utility for both mechanistic discovery and translational research.

• Asunaprevir (BMS-650032): Potent HCV NS3 Protease Inhibit...

  2025-11-07

  Asunaprevir (BMS-650032) is a highly selective hepatitis C virus (HCV) NS3 protease inhibitor with sub-10 nM potency across multiple HCV genotypes. It demonstrates robust hepatotropic distribution and minimal off-target antiviral activity, making it a reference compound for HCV RNA replication inhibition studies.

• DiscoveryProbe™ FDA-approved Drug Library: High-Throughpu...

  2025-11-06

  The DiscoveryProbe™ FDA-approved Drug Library enables high-throughput screening with 2,320 clinically approved compounds, accelerating drug repositioning and target identification. This rigorously curated resource is optimized for diverse biomedical applications, supporting rapid evidence-based discovery.

• 3X (DYKDDDDK) Peptide: Structural Insights & Next-Gen App...

  2025-11-05

  Explore the advanced biochemistry of the 3X (DYKDDDDK) Peptide for epitope tagging and affinity purification of FLAG-tagged proteins. This article uniquely connects cotranslational protein processing, metal-dependent assay design, and structure-function relationships for superior research outcomes.

• 3X (DYKDDDDK) Peptide: Precision Tagging for Dynamic Prot...

  2025-11-04

  Explore the advanced role of the 3X (DYKDDDDK) Peptide in dissecting transient protein-protein interactions and dynamic post-translational modifications. This article offers a unique perspective on how this epitope tag peptide enables high-fidelity analysis of protein networks, surpassing traditional purification and detection methods.

• Redefining Drug Discovery: Mechanistic Insight and Strate...

  2025-11-03

  Explore how the DiscoveryProbe™ FDA-approved Drug Library transforms translational research by enabling rapid drug repositioning, mechanistic pathway analysis, and pharmacological target identification. This thought-leadership article blends mechanistic insight with actionable strategy, referencing recent breakthroughs in AML research, and offers a strategic roadmap for researchers aiming to bridge the gap between bench and bedside.

• DiscoveryProbe™ FDA-approved Drug Library: Transforming L...

  2025-11-02

  Explore how the DiscoveryProbe FDA-approved Drug Library empowers high-throughput screening drug library workflows, integrating advanced LC-MS metabolomics and exposomics for next-generation pharmacological target identification. Discover unique strategies for maximizing drug repositioning and pathway analysis in biomedical research.

• DiscoveryProbe FDA-approved Drug Library: Transforming Hi...

  2025-11-01

  The DiscoveryProbe™ FDA-approved Drug Library empowers researchers to accelerate drug repositioning and novel target discovery with its robust, clinically relevant compound collection. This high-throughput screening drug library brings unparalleled efficiency, reproducibility, and translational insight to cancer research, neurodegenerative disease modeling, and signal pathway regulation.

• DiscoveryProbe FDA-approved Drug Library: Accelerating Tr...

  2025-10-31

  Unlock the power of clinically validated compound libraries with the DiscoveryProbe FDA-approved Drug Library. This high-throughput screening drug library enables rapid drug repositioning and target identification, streamlining workflows in cancer and neurodegenerative disease research. Explore actionable protocols, troubleshooting insights, and breakthrough applications that set this high-content screening compound collection apart.

• DiscoveryProbe™ FDA-approved Drug Library: Structure, Evi...

  2025-10-30

  The DiscoveryProbe™ FDA-approved Drug Library (L1021) is a rigorously curated collection of 2,320 clinically approved bioactive compounds, supporting high-throughput and high-content screening in drug repositioning and target identification. This FDA-approved bioactive compound library offers standardized, ready-to-use solutions, enabling reproducible signal pathway regulation and pharmacological discovery across oncology, neurodegeneration, and more.

• DiscoveryProbe™ FDA-approved Drug Library: Uncovering Nov...

  2025-10-29

  Explore how the DiscoveryProbe FDA-approved Drug Library empowers advanced drug repositioning and pharmacological target identification, with unique insights into mechanism-based screening and translational breakthroughs. Discover a deeper scientific perspective not found in standard product overviews.

• DiscoveryProbe™ FDA-approved Drug Library: Unraveling Com...

  2025-10-28

  Explore how the DiscoveryProbe FDA-approved Drug Library redefines target identification and drug repositioning through integrative high-throughput and high-content screening. Delve into advanced pharmacological applications, mechanistic insights, and unique strategies beyond conventional workflows.

• DiscoveryProbe FDA-approved Drug Library: Accelerating Hi...

  2025-10-27

  The DiscoveryProbe™ FDA-approved Drug Library empowers translational researchers to rapidly identify new therapeutic candidates and mechanisms using clinically validated compounds. Its stability, format flexibility, and depth of annotation set a new standard for high-content screening and pharmacological target identification across cancer, neurodegeneration, and emerging infectious diseases.

• 3X (DYKDDDDK) Peptide: Precision Epitope Tag for Recombin...

  2025-10-26

  The 3X (DYKDDDDK) Peptide is a synthetic epitope tag optimized for the sensitive immunodetection and affinity purification of FLAG-tagged recombinant proteins. This peptide’s triple-repeat structure enhances antibody recognition while minimizing steric hindrance. Its unique properties enable advanced workflows in protein purification, crystallization, and metal-dependent immunoassays.

• 3X (DYKDDDDK) Peptide: Innovations in Affinity Purificati...

  2025-10-25

  Explore the advanced scientific mechanisms and unique metal-dependent applications of the 3X (DYKDDDDK) Peptide in recombinant protein purification, immunodetection, and structural biology. Learn how this DYKDDDDK epitope tag peptide enables high-sensitivity workflows and new research frontiers.

14535 records 16/969 page Previous Next First page 上5页 1617181920 下5页 Last page